Announcements Trials
Browse Landscape

Phase

Phase 2 22Phase 1 4Phase 1/2 3Phase NA 2Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myeloproliferative Disorders 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Leukemia, Lymphocytic, Chronic, B-Cell 5Myelodysplastic Syndromes 4Multiple Myeloma 4Lymphoma, Non-Hodgkin 4Hodgkin Disease 4Graft vs Host Disease 4Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Waldenstrom Macroglobulinemia 2Primary Myelofibrosis 2Myasthenia Gravis 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Biphenotypic, Acute 2Leukemia 2Hematologic Neoplasms 2Anemia, Refractory, with Excess of Blasts 2Testicular Neoplasms 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Neoplasms, Plasma Cell 1Neoplasms 1Myeloproliferative Syndrome, Transient 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Dexamethasone 20Melphalan 13Thalidomide 10Bortezomib 10Lenalidomide 8Cyclophosphamide 8Prednisone 6Filgrastim 6Doxorubicin 6Vincristine 5Epoetin Alfa 5pomalidomide 3Zoledronic Acid 3Peripheral Blood Stem Cell Transplantation 3Idarubicin 3carfilzomib 2Vorinostat 2Radiotherapy 2Interferon-alpha 2Granulocyte Colony-Stimulating Factor 2Early Intervention, Educational 2Darbepoetin alfa 2Carmustine 2Calcium Dobesilate 2Busulfan 2valspodar 1sargramostim 1oblimersen 1liposomal doxorubicin 1isatuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms, Plasma Cell × Mycophenolic Acid × Clear all
NCT03480360 2026-02-19

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

Dartmouth-Hitchcock Medical Center

Phase 3 Active not recruiting
21 enrolled 19 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Refractory, with Excess of Blasts, Lymphoma, Lymphoma, Non-Hodgkin, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Neoplasms, Plasma Cell, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡